Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor

Secondary glioblastoma is a rare brain tumor characterized by a mutation in isocitrate dehydrogenase, which is reported to lead to epigenetic modification. Patients with secondary glioblastoma experience poor survival and quality-of-life outcomes due to the disease’s aggressiveness and a lack of tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurbani, Saumya S, Weinberg, Brent D, Salgado, Eric, Voloschin, Alfredo, Velazquez Vega, Jose Enrique, Olson, Jeffrey J, Shu, Hui-Kuo G, Shim, Hyunsuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104214/
https://www.ncbi.nlm.nih.gov/pubmed/32257248
http://dx.doi.org/10.1093/omcr/omaa006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104214/
https://www.ncbi.nlm.nih.gov/pubmed/32257248
http://dx.doi.org/10.1093/omcr/omaa006

Ejemplares similares